Year-End Report 2024/2025
Positive development in the USA continuesSEK tQ424/25Q423/24May-April 24/25May-April 23/24Net sales2,3321,8998,6197,290Operating profit (loss)-20,341-41,490-85,839-126,845Profit (loss) for the period-20,766-39,532-87,624-124,823Earnings per share …
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Positive development in the USA continues
SEK t |
Q4
24/25
Q4
23/24
May-April 24/25
May-April 23/24
Net sales
2,332
1,899
8,619
7,290
Operating profit (loss)
-20,341
-41,490
-85,839
-126,845
Profit (loss) for the period
-20,766
-39,532
-87,624
-124,823
Earnings per share after dilution
-0.21
-0.47
-0.95
-2.14
Number of shares at the end of the period
97,786,384
84,055,560
92,569,248
84,055,560